Skip to content
healthcare.dev

DIFLUPREDNATE

NDC 69315-329, DIFLUPREDNATE, emulsion, from Leading Pharma, LLC.

Product NDC
69315-329
Status
Listed
Labeler
Leading Pharma, LLC
Dosage form
EMULSION
Route
OPHTHALMIC
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219441
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69315-329 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIFLUPREDNATE.5 mg/mL
Package NDCNDC-11Package
69315-329-05693150329051 BOTTLE in 1 CARTON (69315-329-05) / 5 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/054ca798-454a-41cc-9d08-97bb8bef5620
  • NADAC price for package 69315032905

    GET /v1/drugs/nadac/69315032905

Use it

Look up 69315-329 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69315-329 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69315-329. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.